The Evolving Use of Gemtuzumab Ozogamicin in Acute Myeloid Leukemia

被引：0
|
作者：
Walter, Roland B. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Sch Med, Div Clin Res, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Div Hematol, Med, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Lab Med & Pathol, Seattle, WA 98195 USA
[4] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2021年 / 19卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：152 / 154
页数：3
相关论文
共 50 条
  • [31] Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin
    Cowan, Andrew J.
    Laszlo, George S.
    Estey, Elihu H.
    Walter, Roland B.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 1312 - 1335
  • [32] The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia
    Ali, Sahra
    Dunmore, Helen-Marie
    Karres, Dominik
    Hay, Justin L.
    Salmonsson, Tomas
    Gisselbrecht, Christian
    Sarac, Sinan B.
    Bjerrum, Ole W.
    Hovgaard, Doris
    Barbachano, Yolanda
    Nagercoil, Nithyanandan
    Pignatti, Francesco
    ONCOLOGIST, 2019, 24 (05): : E171 - E179
  • [33] Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia
    Swaminathan, Mahesh
    Cortes, Jorge E. E.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [34] Gemtuzumab ozogamicin (Mylotarg®) in children with refractory or relapsed acute myeloid leukemia
    Reinhardt, D
    Diekamp, S
    Fleischhack, G
    Corbacioglu, S
    Jürgens, H
    Dworzak, M
    Kaspers, G
    Creutzig, U
    Zwaan, CM
    ONKOLOGIE, 2004, 27 (03): : 269 - 272
  • [35] Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia -: Ongoing trials
    Gleissner, Beate
    Schlenk, Richard
    Bornhaeuser, Martin
    Berdel, Wolfgang E.
    ONKOLOGIE, 2007, 30 (12): : 657 - U1
  • [36] Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia
    Cortes, Jorge E.
    de Lima, Marcos
    Dombret, Herve
    Estey, Elihu H.
    Giralt, Sergio A.
    Montesinos, Pau
    Roellig, Christoph
    Venditti, Adriano
    Wang, Eunice S.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [37] Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia
    Jorge E. Cortes
    Marcos de Lima
    Hervé Dombret
    Elihu H. Estey
    Sergio A. Giralt
    Pau Montesinos
    Christoph Röllig
    Adriano Venditti
    Eunice S. Wang
    Journal of Hematology & Oncology, 13
  • [38] Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drug
    Rowe, Jacob M.
    Lowenberg, Bob
    BLOOD, 2013, 121 (24) : 4838 - 4841
  • [39] Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia
    Jennifer Hibma
    Beverly Knight
    Clinical Pharmacokinetics, 2019, 58 : 335 - 347
  • [40] Azacitidine combined with gemtuzumab ozogamicin in patients with relapsed/refractory acute myeloid leukemia
    Bayraktar, Ulas Darda
    Domingo, Gelenis Calzadilla
    Schmit, Jessica
    Pereira, Denise
    LEUKEMIA & LYMPHOMA, 2011, 52 (05) : 913 - 915
12345